⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Kenneth WiesnerM.D.

Rheumatology · Sacramento, CA 95825

NPI: 1033287545

Share:

13

🟢 Low

Risk Flags

Elevated cost per beneficiaryOpioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

9,747

Total Claims

$5.6M

Drug Cost

903

Beneficiaries

$6,195

Cost/Patient

Risk Score Breakdown 13/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+185%

Opioid rate vs peers

11.6% vs 4.1% avg

+3%

Cost per patient vs peers

$6,195 vs $6,039 avg

+34%

Brand preference vs peers

10.2% vs 7.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

11.6%

Opioid Rate

1,127

Opioid Claims

$36K

Opioid Cost

5.9%

Long-Acting Rate

Brand vs Generic

90% generic

Brand: 984 claims · $5.2M

Generic: 8,683 claims · $341K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Etanercept169$1.2M
Adalimumab107$1.2M
Etanercept120$935K
Adalimumab61$645K
Certolizumab Pegol16$134K
Belimumab26$126K
Apremilast16$104K
Secukinumab13$90K
Adalimumab12$90K
Golimumab13$83K
Secukinumab12$81K
Abatacept11$71K
Tocilizumab13$70K
Infliximab13$62K
Abatacept11$58K

Prescribing Profile

82

Unique Drugs

$2.2M

IRA Negotiated Drugs

13.0

Anomaly Score

Patient Profile

74

Avg Age

73%

Female

1.37

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About